TerminatedPhase 1/2

Validation of ICG to Identify the Urethra During Rectal Surgery

Stopped: Technique failed

United Kingdom5 participantsStarted 2017-07-11

Plain-language summary

This is an open-label feasibility study utilising direct instillation of ICG into the urethra during surgery for low rectal cancers. The trial involves a single intervention taking place during the patient's operation. Participants will be included in the study for around 2 months with time either side of the intervention to collect background data.

Who can participate

Age range18 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Participant is willing and able to give informed consent for participation in the study. * Male, aged 18 years or above. * Undergoing low rectal surgery where the operating field will be close to the urethra Exclusion Criteria: * Participant has an allergy to iodine or ICG * Known liver failure

What they're measuring

Number of urethras identified under white light and fluorescence

Timeframe: 1 day

Trial details

NCT IDNCT03204201

SponsorOxford University Hospitals NHS Trust

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-07-01

View on ClinicalTrials.gov More Urethra Injury trials